PRKACA and chronic obstructive pulmonary disease: Topological analysis of the protein interaction network revealed that SRC, HIF1A, NFKB1, HDAC2, and PRKACA could be the core targets of Bailing capsules, potentially improving lung function, enhancing exercise endurance, and reducing acute exacerbations of COPD.